NCT00308529View on ClinicalTrials.gov

Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

January 31, 2009

Conditions
Carcinoma, Small Cell LungLung Cancer
Interventions
DRUG

irinotecan

DRUG

carboplatin

DRUG

bevacizumab

PROCEDURE

Radiation Therapy

Trial Locations (4)

33901

Florida Cancer Specialists, Fort Myers

37023

Tennessee Oncology, PLLC, Nashville

37404

Chattanooga Oncology Hematology Associates, Chattanooga

45242

Oncology Hematology Care, Cincinnati

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER